Grupo 1: Fisiopatología e Investigación Clínica de las Enfermedades de Base Inmunológica e Inflamatoria Crónicas

Código de grupo: 5.01
Tipo de grupo: Consolidado
Descripción del grupo: Fisiopatología e investigación clínica de las enfermedades de base inmunológica e inflamatoria crónicas.
Jefe de Grupo: Dr. Eduardo Fernández-Cruz Pérez

  • Este grupo ha integrado recientemente a los investigadores del Grupo 5.04 Inmuno-Oncología que desaparece como tal.
Integrantes del grupo
Investigadores y personal de apoyo
ALARCON ESCUDERO ALBA First Stage Researcher
ALONSO ARMENDARIZ ROCIO First Stage Researcher
ARNAIZ VILLENA ANTONIO Established Researcher
BALASTEGUI MARTÍN HÉCTOR First Stage Researcher
BARRIO ALONSO CELIA
CAHUANA PÉREZ MARIO ALBERTO Lab Technician
CARBONE CAMPOVERDE JAVIER ALBERTO Established Researcher
DI NATALE MARISA First Stage Researcher
DIAZ LUNA MARIA MERCEDES First Stage Researcher
ESTECHA PALOMERO ANA Recognised Researcher
EZZAHOURI EL KHALOUKI IKRAM First Stage Researcher
FERNÁNDEZ-CRUZ PÉREZ EDUARDO Leading Researcher
FUENTELSAZ ROMERO SARA
GARCÍA JIMÉNEZ SANDRA First Stage Researcher
GARCIA MARTINEZ ELENA First Stage Researcher
GIL HERRERA JUANA Established Researcher
GOMEZ PEREZ JIMENA First Stage Researcher
LIMAY CARRE KRISTOFER MIGUEL
LOPEZ NARES ADRIAN First Stage Researcher
LOPEZ NAVARRO BALTASAR
MARTÍN VILLA JOSÉ MANUEL Established Researcher
MARTINEZ QUILES NARCISA Established Researcher
MEJÍA GONZÁLEZ MARÍA ALEJANDRA First Stage Researcher
MONTANCHEZ MATEO JUDITH
NAVARRO CASPISTEGUI JOAQUÍN Established Researcher
PÉREZ GARCÍA YAIZA
PUIG KRÖGER AMAYA ROCIO Established Researcher
RODRÍGUEZ SAINZ MARÍA CARMEN Established Researcher
SAMANIEGO GARCÍA RAFAEL Recognised Researcher
SÁNCHEZ-MATEOS RUBIO PALOMA Established Researcher
SANCHEZ MARTIN ALICIA
SCHIAFFINO GARCIA-VILLANOVA TERESA First Stage Researcher
TORRES TORRESANO MÓNICA Lab Technician
Líneas de Investigación
Axis 1. Immunotherapy with immunomodulatory agents in immunomediated pathologies.

L1: Immunomodulation of innate, adaptive and genetic responses with immunomodulatory agents in the treatment of immune-mediated diseases.

Axis 2. Study of immunopathogenic mechanisms in: (2.1) Primary Immunodeficiencies and (2.2) Secondary to emerging virus infections (SARS-CoV2); (2.4) Immuno-oncology; (2.7) Autoimmune Chronic Inflammatory Diseases; (2.9) Reproductive Failures and (2.10) Solid Organ Transplantation.

L1: Primary immunodeficiencies: immunopathogenesis, classification and treatment.

L2: Study of specific memory T-cell responses to SARS-CoV2.

L3: Biomarkers in secondary immunodeficiencies.

L4: Cell migration in cancer.

L5: Tumour macrophages in melanoma

L6: Study of the efficacy of combining immunotherapy and radiotherapy in different human tumours.

L7: Immunology of autoimmune chronic inflammatory diseases.

L8: Role of macrophages in Autoimmune Inflammatory Diseases

L9: Reproductive Immunology

L10: Transplantation Immunology

Axis 3: Immunology and HLA; Population Genetics and Signal Transduction

                L1: Immunology and HLA

L2: Population genetics

L3: Signal transduction

First decile publications 4 260,8
First quartile publications 15 321,1
Second quartile publications 7 31,7
Third quartile publications 2 5,2
Total publications (including those without IF) 26 363,4

 

 

 

 

 

 

 

 

 

 

 

 

SUBIR ↑